|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Lineagen, Inc. Selected to Present at the 2010 Genetic Risk Factors for Autism: Translating Discoveries into Diagnostics Symposium in Toronto
9/2/2010 10:39:57 AM
SALT LAKE CITY--(BUSINESS WIRE)--Lineagen, Inc. (www.lineagen.com), a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders, announced today that Dr. Michael S. Paul, the Company’s President & Chief Executive Officer, was selected to present at the “Genetic Risk Factors for Autism: Translating Discoveries into Diagnostics” symposium, being held September 1-2, 2010 at the Old Mill Inn and Spa in Toronto, Ontario, Canada. The international symposium, sponsored in part by Autism Speaks, the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the United States National Institute of Health (NIH), and the Canadian Institutes of Health Research (CIHR), serves as a forum to address the scientific, clinical, ethical, and related aspects of translating new Autism Spectrum Disorders (ASD) genetic discoveries into clinical screening and diagnostic tools.
|
|
|
|
|
|
|
|
|
|
|